VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 223 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $49,323 | +0.7% | 4,869 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $48,982 | +7.4% | 4,869 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $45,623 | -59.4% | 4,869 | +6.4% | 0.00% | -60.0% |
| Q2 2023 | $112,249 | +1.2% | 4,576 | +4.4% | 0.01% | 0.0% |
| Q4 2022 | $110,908 | +31.3% | 4,382 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $84,485 | -24.3% | 4,382 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $111,610 | +11.0% | 4,382 | +12.1% | 0.01% | +25.0% |
| Q1 2022 | $100,565 | -84.4% | 3,910 | -74.7% | 0.00% | -55.6% |
| Q4 2021 | $646,640 | -8.7% | 15,444 | -5.1% | 0.01% | -10.0% |
| Q3 2021 | $708,114 | -8.1% | 16,271 | +8.3% | 0.01% | -16.7% |
| Q1 2021 | $770,280 | +83.3% | 15,024 | -4.3% | 0.01% | +100.0% |
| Q4 2020 | $420,205 | -22.0% | 15,691 | 0.0% | 0.01% | -33.3% |
| Q3 2020 | $538,672 | -7.5% | 15,691 | +10.4% | 0.01% | -10.0% |
| Q2 2020 | $582,348 | +580.0% | 14,214 | +468.8% | 0.01% | +400.0% |
| Q1 2020 | $85,641 | – | 2,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $39,700,000 | 30.52% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $565,858,000 | 4.50% |
| Zebra Capital Management LLC | 25,419 | $647,000 | 1.90% |
| Alaska Permanent Fund Corp | 2,300,000 | $58,581,000 | 0.84% |
| CLARK ESTATES INC/NY | 180,000 | $4,585,000 | 0.79% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $142,697,025 | 0.78% |
| SECTOR GAMMA AS | 110,223 | $2,807,000 | 0.63% |
| Avidity Partners Management LP | 758,211 | $19,312,000 | 0.44% |
| New Vernon Capital Holdings II LLC | 14,501 | $369,000 | 0.30% |
| DUALITY ADVISERS, LP | 116,415 | $2,965,000 | 0.29% |